Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Analytical Biochemistry
|
September 22, 2012
A time-resolved fluorescence resonance energy transfer assay suitable for high-throughput screening for inhibitors of immunoglobulin E-receptor interactions
Beomkyu Kim, Svetlana S Tarchevskaya, Alexander Eggel, et al.
The Journal of Allergy and Clinical Immunology
|
November 24, 2024
Flow cytometry-based basophil and mast cell activation tests in allergology: State of the art
Didier G Ebo, Rajia Bahri, Alexander Eggel, et al.
Nature
|
October 30, 2012
Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor
Beomkyu Kim, Alexander Eggel, Svetlana S Tarchevskaya, et al.
The Journal of Allergy and Clinical Immunology
|
May 15, 2021
Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions
Luke F Pennington, Pascal Gasser, Daniel Brigger, et al.
The Journal of Allergy and Clinical Immunology
|
October 13, 2025
High-affinity omalizumab variants with optimized disruptive potency prevent anaphylaxis in vivo
Daniel Brigger, Pascal Guntern, Luke F Pennington, et al.
The Journal of Biological Chemistry
|
September 6, 2012
An engineered disulfide bond reversibly traps the IgE-Fc3-4 in a closed, nonreceptor binding conformation
Beth A Wurzburg, Beomkyu Kim, Svetlana S Tarchevskaya, et al.
Cell Death & Disease
|
May 5, 2018
IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils
Fabian Zellweger, Patrick Buschor, Gabriel Hobi, et al.
Nature Communications
|
December 4, 2021
Directed evolution of and structural insights into antibody-mediated disruption of a stable receptor-ligand complex
Luke F Pennington, Pascal Gasser, Silke Kleinboelting, et al.
Allergy
|
September 29, 2025
Age-Related Increase in Anaphylaxis Severity Is Associated With Enhanced Sensitivity to Allergic Mediators
Daniel Brigger, Melanie Steinmann, Nadine Roos, et al.
The World Allergy Organization Journal
|
October 3, 2022
The rationale for development of ligelizumab in food allergy
Robert A Wood, R Sharon Chinthrajah, Alexander Eggel, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Analytical Biochemistry
|
September 22, 2012
A time-resolved fluorescence resonance energy transfer assay suitable for high-throughput screening for inhibitors of immunoglobulin E-receptor interactions
Beomkyu Kim, Svetlana S Tarchevskaya, Alexander Eggel, et al.
The Journal of Allergy and Clinical Immunology
|
November 24, 2024
Flow cytometry-based basophil and mast cell activation tests in allergology: State of the art
Didier G Ebo, Rajia Bahri, Alexander Eggel, et al.
Nature
|
October 30, 2012
Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor
Beomkyu Kim, Alexander Eggel, Svetlana S Tarchevskaya, et al.
The Journal of Allergy and Clinical Immunology
|
May 15, 2021
Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions
Luke F Pennington, Pascal Gasser, Daniel Brigger, et al.
The Journal of Allergy and Clinical Immunology
|
October 13, 2025
High-affinity omalizumab variants with optimized disruptive potency prevent anaphylaxis in vivo
Daniel Brigger, Pascal Guntern, Luke F Pennington, et al.
The Journal of Biological Chemistry
|
September 6, 2012
An engineered disulfide bond reversibly traps the IgE-Fc3-4 in a closed, nonreceptor binding conformation
Beth A Wurzburg, Beomkyu Kim, Svetlana S Tarchevskaya, et al.
Cell Death & Disease
|
May 5, 2018
IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils
Fabian Zellweger, Patrick Buschor, Gabriel Hobi, et al.
Nature Communications
|
December 4, 2021
Directed evolution of and structural insights into antibody-mediated disruption of a stable receptor-ligand complex
Luke F Pennington, Pascal Gasser, Silke Kleinboelting, et al.
Allergy
|
September 29, 2025
Age-Related Increase in Anaphylaxis Severity Is Associated With Enhanced Sensitivity to Allergic Mediators
Daniel Brigger, Melanie Steinmann, Nadine Roos, et al.
The World Allergy Organization Journal
|
October 3, 2022
The rationale for development of ligelizumab in food allergy
Robert A Wood, R Sharon Chinthrajah, Alexander Eggel, et al.
Page
of 4